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Summary Points
• Worldwide, 8.5 million infants aged less than 6 months (<6m) are acutely malnourished. For the first time, 2013 WHO Malnutrition Guidelines describe their treatment,
but on the basis of “very low quality” evidence, per WHO. More and better research is
urgently needed.
• To prioritise the many possible research questions on infant <6m malnutrition, we used
the systematic, transparent, well-established Child Health and Nutrition Research Initiative (CHNRI) approach. Sixty-four experts scored 60 research questions on the basis of
their answerability, likelihood of intervention efficacy, effectiveness, deliverability, sustainability, impact on disease burden, and impact on equity.
• “How should infant <6m SAM be defined?” was the top-scoring research question; that
this and other basic questions are still needed highlights paucity of evidence on this
topic.
• Other leading questions reflect interest in public health/community-focused models of
care, e.g., “What are priority components of a package of outpatient care?” These questions are important to inform new outpatient strategies now recommended by WHO.
• Most of our questions received high-priority scores reflecting a great need for a wide variety of evidence. Several major global initiatives such as the “Scaling Up Nutrition Movement” and “Generation Nutrition” would benefit from better evidence. Our results show
clear ways forward for future research investments.
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Background
Undernutrition is responsible for some 3.1 million child deaths per year, 45% of all deaths
among children aged <5 years [1]. Infants are most at risk [2,3]. Acute malnutrition (comprising wasting, as defined by low weight-for-length; and/or low mid-upper arm circumference;
and/or oedematous malnutrition, Kwashiorkor) is particularly important because of its high
case fatality rate [4,5].
In the last decade, the management of acute malnutrition has been revolutionized by a new
public health-orientated approach to treatment, “Community-based Management of Acute
Malnutrition” (CMAM) [6]. To achieve impact, CMAM focuses on: high programme coverage;
treatment of “uncomplicated” cases on an outpatient basis; the use of nutrient-dense “readyto-use therapeutic food” [7]. Programmes are targeted at children aged 6 to 59 months. Contrasting this success, the management of acute malnutrition in infants under six months old
(<6m) is often neglected in practice even if described in clinical protocols [8]. When it is described, guidelines focus on inpatient-based care alone [9]. Yet, recent estimates suggest that an
estimated 3.8 million infants <6m have severe acute malnutrition (SAM) [10]. This is a minimum estimate since it does not include oedematous SAM. A further 4.7 million infants are estimated to have moderate acute malnutrition (MAM) [10].
Recently updated (December 2013) World Health Organization (WHO) guidelines on the
“Management of Severe Acute Malnutrition in Infants and Children” for the first time have a
chapter devoted to infants <6m [11]. Other key firsts in these guidelines are: distinguishing between “complicated” (i.e., clinically sick) and “uncomplicated” (i.e., malnourished but clinically
stable and able to eat) cases of infant <6m SAM; outlining outpatient as well as inpatientbased treatment options [11]. This represents significant progress. However, whilst many of
the WHO recommendations on infants <6m are “strong” [12], the quality of evidence underlying them is “very low” [11,12]. The need for research is widely recognised [11,13,14]. Given
that many research options (questions) are possible and that undertaking any of them requires
significant investment of time and resources, it is vital to concentrate on the most important
questions. A research prioritisation exercise focused on infants <6m is especially timely, relevant, and useful because:
• Nutrition plays a key role in the 2015 Millennium Development Goals (MDGs) [15] and will
continue to matter beyond 2015 [16,17].
• In May 2014, a multi-agency global campaign, “Generation Nutrition” was launched. Its ultimate aim is to “End child deaths from acute malnutrition” [18].
• In November 2014, the first ever “Global Nutrition Report” highlighted a lack of progress
on ending child wasting. It also noted the need to improve coverage of SAM treatment services [17].
• The “Scaling Up Nutrition” (SUN) Movement is a rapidly expanding global movement with
54 countries currently signed up [16]. It focuses on the first 1,000 days of life as a critical window of opportunity to improve nutrition; malnourished infants <6m fall within the movement’s scope.
We used the well-established Child Health and Nutrition Research Initiative (CHRNI) methodology [19] to consult key stakeholders on a range of research questions in order to identify
the most important. We intend this data to be useful in informing the research agenda of governments, researchers, investors, international organisations, and national agencies about what
is likely to result in high-impact policies and practices in the management of acute malnutrition in infants <6m (MAMI) in resource-poor settings.
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Methods
CHNRI methodology is described in detail elsewhere: on the website (http://www.chnri.org/
index.php), in a methods paper [19], and in other papers using CHNRI to explore other key
areas of global health [20–24]. It represents an important improvement on traditional research-priority—setting methods, such as literature searches to find gaps in research or comparing the burden of disease and estimating economic “payback,” because it is systematic and
transparent about the range of possible research questions and how their final ranks have been
derived. Full protocols are described in S1 Text. In brief:
We began by defining the context and criteria for priority setting. Working as a “core
group” of authors of this paper, we developed a long list of possible research questions based
on previous publications [8], meetings and discussions. By careful phrasing and consolidation
of overlapping ideas, we edited and refined these to a manageable final list of 60 questions divided into three categories: (1) basic epidemiological research, (2) health policy and systems research, and (3) technical questions and interventions. Based on CHNRI’s conceptual
framework, we also agreed on seven judging criteria (Table 1).
As with other CHNRIs, it was up to individual respondents to interpret and imagine what
future interventions might be and how they might meet or not meet the various criteria. We
did not apply weights to these judging criteria (as some CHNRI projects have done) because infant <6m malnutrition is a new and focused area of research and we felt that un-weighted estimates would be clearer and more interpretable by our intended policy audience. Should
readers using our data wish for any reason (e.g., to reflect context-specific priorities) to weight
certain areas more than others, this is possible using the results spreadsheet in S1 Table and referring to CHNRI methods [19].
We distributed the list of questions and scoring criteria as an online survey to a total of 150
technical experts, experienced practitioners, and policy makers in the field of nutrition and
child health (MAMI “reference group”). These were identified from participation at meetings
and symposia related to nutrition and/or infant and young child feeding and represented a

Table 1. CHNRI judging criteria for each research question (option).
CHNRI Criterion

How participants were asked to assess the criterion

Answerability

Would you say that a study to answer this research question is possible (e.g.,
feasible, ethically possible, well deﬁned endpoints/outcomes)?

Efﬁcacy

Would the intervention(s) arising from the proposed research be efﬁcacious (i.e.,
under research/optimally resourced conditions)?

Effectiveness

Would the intervention(s) arising from the proposed research likely be effective
(i.e., under routine programme conditions)?

Deliverability

Would the intervention arising from the research be deliverable (taking into
account, for example, design, standardization, safety, health system
infrastructure, human resources, and role of attitudes and demand)?

Sustainability

Would the interventions arising from the research be sustainable (taking into
account, for example, ﬁnancial affordability, adequacy of regulation, monitoring
and enforcement, partnership and coordination between civil society and
external donor agencies, and favourable political climate)?

Disease Burden
Reduction

Would you say that interventions arising from the research would eventually
(assuming high deliverability, affordability and sustainability) contribute to a
signiﬁcant reduction in infant malnutrition or mortality or morbidity?

Equity

Would you say that interventions arising from the research have potential to
improve equity in disease burden distribution (i.e., could help all segments of the
society, not just the privileged ones)?

doi:10.1371/journal.pmed.1001812.t001
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breadth and depth of expertise, as well as a wide spectrum of stakeholder organisations. An
open invitation to participate was also posted on internet-based technical discussion forums.
Respondents applied each of the seven judging criteria to each of the 60 questions listed by a
“Yes” (1 point), “No” (0 points), “Undecided” (0.5 points), or “Insufficiently informed” (missing input). Based on these responses, a research priority score (RPS) for each criterion and an
overall RPS were calculated. These could range between 0% (lowest possible RPS) and 100%
(highest possible RPS). The final list of priorities with criterion-specific and overall priority
scores for all 60 research options is presented in S1 Table.
As well as the overall RPS given to various research options, we also assessed the level of
agreement between scorers through the “average expert agreement” (AEA). This could range
between 1 (perfect agreement between all respondents) and 0 (no agreement) [19].

Ethics
As is standard for CHNRI projects, formal ethics review was not needed since the work does
not involve any personal or otherwise sensitive data and deals with professional participants
rather than patients, all solicited via established professional networks. Participants were aware
that their responses would be used for research and publication. Those who completed the
questionnaire were asked whether they were happy to be named as part of the group author
list, and only those answering “yes” are listed. Individual answers to the questions are not presented and so were anonymous.

Respondents
Sixty-four individuals participated in the survey (Table 2). They comprise the MAMI Working
Group collaborating authors. Nine out of the 14 original MAMI group took part. Seven others
took part anonymously. This represents a 42.6% response rate for directly invited participants.
Sixty-four percent of respondents were invited directly and the rest came through posts on
technical forums or word of mouth through invitees. Thirty-four respondents completed part
1 only, 20 completed part 2 only, and ten completed both parts.

Research Priorities
S1 Table provides the full list of questions and their scores in excel format. Table 3 shows the
15 research questions that achieved the highest overall research priority score (RPS). These
achieved high scores across all of the judging criteria.
It is revealing of the current state of research around infant <6m SAM that many of the top
questions are very basic. Most striking was the number-one question: “How should infant <6m
Table 2. Profile of respondents (n = 64).
Main employer (n)

Main type of work (n)

Rural or Urban (n)

Mainly based in (n)
Europe (31)

Non-governmental organisation (NGO) (27)

Operational / programme (35)

Both (42)

Academic Institution (16)

Academic (19)

Rural only (16)

North America (13)

United Nations (UN) agency (8)

Policy (4)

Urban only (6)

Eastern Africa (9)

Government Institution (6)

Other (6)

Independent (7)

South Asia (4)
Southern Africa (3)
West Africa (2)
Central America / Caribbean (1)
Australasia (1)

doi:10.1371/journal.pmed.1001812.t002
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Question
number
1
26

50

48

29

14

58

18

21

27

28

22

Research option (question)

How should infant <6m SAM be
deﬁned?

What are/is the key opportunities/
timing when infant SAM management
can be incorporated with other
healthcare programmes?

What are the priority components of a
package of care for outpatient
treatment of infant <6m SAM?

Having detected SAM in the
community, what is the efﬁcacy of
providing targeted skilled
breastfeeding support to caregivers of
stable infants?

How can existing tools be adapted
and/or linked together to better
identify and manage infant <6m
SAM?

What are the most feasible tools and
techniques for assessing treatment
programme coverage for infant <6m
SAM?

What is the feasibility, effectiveness,
cost-effectiveness and impact of
different approaches to promote early
initiation and exclusivity of
breastfeeding?

What are the main barriers to existing
inpatient interventions for infant <6m
SAM and how might they be best
addressed?

What is the effectiveness, cost, and
safety of an outpatient-focused
treatment model for infants with SAM?

Which supervision tools and
approaches are most effective
towards improving the front-line case
management of infant <6m SAM?

How can existing child health and
nutrition reporting systems be adapted
to capture, monitor and audit data on
infant <6m SAM?

What role do CMAM programmes
have in delivering outpatient-based
treatment for infant <6m SAM?

12

11

10

9

8

7

6

5

4

3

2

1

Rank

90.8

92.7

95.0

89.2

93.9

91.3

89.5

91.7

86.9

85.9

98.8

94.3

Answerability

86.4

91.4

86.8

84.3

93.1

95.6

86.1

88.9

95.6

92.6

90.5

89.5

Efﬁcacy

89.7

80.0

89.7

93.3

92.2

86.4

88.2

87.9

88.7

95.0

85.9

94.1

Effectiveness

78.6

96.6

91.4

84.5

87.9

91.4

100.0

91.1

87.9

94.8

93.1

98.3

Deliverability

82.7

92.3

89.3

78.8

83.9

88.9

92.6

96.2

87.5

89.3

90.4

89.7

Sustainability

93.8

83.3

84.0

93.8

80.0

86.0

84.6

94.2

98.0

94.0

92.0

90.4

Disease
burden
reduction

Table 3. The 15 research options that achieved the highest overall research priority score (%) with average expert agreement (range 0–1).

89.6

76.1

77.1

89.6

89.6

83.3

82.0

81.3

88.0

83.3

84.8

91.7

Equity

0.71

0.73

0.70

0.69

0.72

0.78

0.59

0.80

0.57

0.68

0.79

0.89

AEA

(Continued)

87.3

87.5

87.6

87.6

88.7

89.0

89.0

90.2

90.4

90.7

90.8

92.6

RPS
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5

13

7

How does breastfeeding status and/or
change in breastfeeding status impact
on infant <6m SAM?

What is the coverage of existing
treatment programmes for infant <6m
SAM?

How can existing surveys of differing
designs and at different levels be
adapted to include infants <6m?

doi:10.1371/journal.pmed.1001812.t003

Question
number

Research option (question)

Table 3. (Continued)

15

14

13

Rank

90.0

89.3

93.2

Answerability

90.9

78.6

90.5

Efﬁcacy

81.7

84.4

90.9

Effectiveness

83.9

84.5

91.4

Deliverability

86.5

90.4

82.1

Sustainability

73.9

81.3

88.5

Disease
burden
reduction

90.5

93.8

74.0

Equity

85.3

86.0

87.2

RPS

0.71

0.84

0.79

AEA

SAM be defined?” Until we know how to define a problem, efforts to address it are likely to be
seriously impaired. This lack of consensus on a case definition is a fundamental block in moving
forward. It reflects distinguishing characteristics between infants <6m and older children regarding assessment: anthropometric measurement is more challenging [25]; some anthropometric indicators are not available (e.g., WHO weight-for-length standards do not exist for length
<45 cm); clinical and feeding history matter more in infants than in older children yet can be
difficult to assess. Though there is evidence that it could be successfully used [26, 27], mid-upper
arm circumference (MUAC) measurement is not currently considered suitable for infants <6m.
MUAC has been key for the treatment of acutely malnourished children over 6 months old since
it enables detection in the community and high treatment programme coverage [28].
Other leading questions reflect an interest in public health/community approaches to
infant <6m SAM management, for example, the questions ranked third, “What are the priority
components of a package of care for outpatient treatment of infant <6m SAM?”; fourth, “Having detected SAM in the community, what is the efficacy of providing targeted skilled breastfeeding support to caregivers of stable infants?”; ninth, “What is the effectiveness, cost, and
safety of an outpatient-focused treatment model for infants with SAM?”; and twelfth, “What
role do CMAM programmes have in delivering outpatient-based treatment for infant <6m
SAM?”. These rankings align well with the new WHO policy to distinguish between “complicated” and “uncomplicated” infant <6m SAM. Once classified in this way, outpatient treatment options are made possible for uncomplicated cases: details of these are vague in the
WHO guidelines [11], so it is helpful that our CHNRI has given options. Outpatient care is a
significant shift away from previous guidelines, which implied that all infants <6m automatically need admission [9].
The Average Expert Agreement (AEA) for the top 15 questions was overall high, indicating
good agreement between the different expert respondents. The highest scoring research option
also received the highest AEA score (0.89), indicating the strongest agreement about the importance of this particular research question. High overall AEA also reflects the paucity of current evidence around infant <6m SAM. Other CHNRIs have a wider distribution of RPS. With
the exception of the bottom six research questions, all those we put out had an overall RPS of
70% and above. This means that our experts saw them as all being important; since infant
<6m SAM has been a previously neglected area of research, much is still unknown.
Two questions stood out as having low AEA: “What is the efficacy of providing targeted
skilled breastfeeding support to caregivers of stable infants <6m?” and “What are the most feasible tools and techniques for assessing treatment programme coverage for infant <6m SAM?”
This implies a lack of consensus about the importance of these questions.
Table 4 shows the same 15 research questions that achieved the highest overall RPS sorted
by research category. There was a fairly even spread covering basic epidemiology, health policies, and systems and technical interventions. This illustrated that there are multiple MAMI research priorities across a variety of areas that are not mutually exclusive. It also suggests that
the CHNRI method was able to compare and discriminate among research questions from different areas and that there was no systematic bias against questions from any of the three
research areas.
Table 5 shows the ten research questions that achieved the lowest overall RPS (relative to
the other questions). The absolute score for many of these questions was still high. Many of
these deal with issues pertaining to a subgroup of malnourished infants <6m, e.g., orphans, infants with disabilities, infants with lactose intolerance and those requiring artificial feeding
and/or possible early introduction of complementary feeds. These questions tended to score
low on deliverability, effectiveness, and disease burden reduction. Though the bottom questions may not have the greatest overall impact, it does not mean that they are not worth
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21

27

28

22

What is the effectiveness,
cost, and safety of an
outpatient-focused treatment
model for infants with SAM?

Which supervision tools and
approaches are most effective
towards improving the frontline case management of
infant <6m SAM?

How can existing child health
and nutrition reporting systems
be adapted to capture, monitor
and audit data on infant <6m
SAM?

What role do CMAM
programmes have in delivering
outpatient-based treatment for
infant <6m SAM?

7

How can existing surveys of
differing designs and at
different levels be adapted to
include infant <6m?

18

13

What is the coverage of
existing treatment programmes
for infant <6m SAM?

What are the main barriers to
existing inpatient interventions
for infant <6m SAM and how
might they be best addressed?

5

How does breastfeeding status
and/or change in
breastfeeding status impact on
infant <6m SAM?

26

14

What are the most feasible
tools and techniques for
assessing treatment
programme coverage for infant
<6m SAM?

What are/is the key
opportunities/timing when
infant SAM management can
be incorporated with other
healthcare programmes?

1

How should infant <6m SAM
be deﬁned?

Basic
epidemiological
research

Health policy and
system research

Q.
#

Research question

Research
instrument

12

11

10

9

8

2

15

14

13

6

1

Rank

90.8

92.7

95.0

89.2

93.9

98.8

90.0

89.3

93.2

89.5

94.3

Answerability

86.4

91.4

86.8

84.3

93.1

90.5

90.9

78.6

90.5

86.1

89.5

Efﬁcacy

Table 4. The 15 top research questions ordered according to research instrument (area).

89.7

80.0

89.7

93.3

92.2

85.9

81.7

84.4

90.9

88.2

94.1

Effectiveness

78.6

96.6

91.4

84.5

87.9

93.1

83.9

84.5

91.4

100

98.3

Deliverability

82.7

92.3

89.3

78.8

83.9

90.4

86.5

90.4

82.1

92.6

89.7

Sustainability

93.8

83.3

84.0

93.8

80.0

92.0

73.9

81.3

88.5

84.6

90.4

Disease
burden

89.6

76.1

77.1

89.6

89.6

84.8

90.5

93.8

74.0

82.0

91.7

Equity

0.71

0.73

0.70

0.69

0.72

0.79

0.71

0.84

0.79

0.59

0.89

AEA

(Continued)

87.3

87.5

87.6

87.6

88.7

90.8

85.3

86.0

87.2

89.0

92.6

RPS

PLOS Medicine | DOI:10.1371/journal.pmed.1001812 April 21, 2015
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48

29

58

Having detected SAM in the
community, what is the
efﬁcacy of providing targeted
skilled breastfeeding support
to caregivers of stable infants?

How can existing tools be
adapted and/or linked together
to better identify and manage
infant <6m SAM?

What is the feasibility,
effectiveness, costeffectiveness and impact of
different approaches to
promote early initiation and
exclusivity of breastfeeding?

doi:10.1371/journal.pmed.1001812.t004

50

What are the priority
components of a package of
care for outpatient treatment of
infant <6m SAM?

Technical
questions and
interventions

Q.
#

Research question

Research
instrument

Table 4. (Continued)

7

5

4

3

Rank

91.3

91.7

86.9

85.9

Answerability

95.6

88.9

95.6

92.6

Efﬁcacy

86.4

87.9

88.7

95.0

Effectiveness

91.4

91.1

87.9

94.8

Deliverability

88.9

96.2

87.5

89.3

Sustainability

86.0

94.2

98.0

94.0

Disease
burden

83.3

81.3

88.0

83.3

Equity

89.0

90.2

90.4

90.7

RPS

0.78

0.80

0.57

0.68

AEA
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57

30

47

43

4

25

40

45

37

19

What is the feasibility, effectiveness,
and cost (effectiveness) of
interventions addressing societal and
political risk factors of infant <6m
SAM?

What is the feasibility, validity, and
accuracy of using reduced growth
velocity to identify, monitor, and
discharge infants at high risk of
mortality?

What is the feasibility, acceptability,
and cost (including time) of wet nursing
as an option for infants who cannot be
breastfed by their mother (e.g.,
orphans)?

What is the efﬁcacy of any
supplementary feeds versus exclusive
breastfeeding only where this is
feasible?

What proportion of infant <6m with
SAM have underlying disability or other
chronic conditions?

How can programmes manage artiﬁcial
feeding so that there is appropriately
targeted and adequate support to
individual infants without “spilling over”
to others?

What is the effectiveness and cost
(effectiveness) of specialised lactosefree formula during inpatient
stabilisation feeds, and how might
lactose-intolerant infants be identiﬁed?

Is there a role for early introduction of
complementary feeding before 6
months of age, and in which subgroup
of infants would this be indicated?

Should there be separate guideline
sections such that slightly different
interventions may be appropriate for
different age groups?

What is the feasibility, effectiveness,
and cost (effectiveness) of setting up
breast milk banking systems in
different settings?

doi:10.1371/journal.pmed.1001812.t005

Question
number

Research Question

60

59

58

57

56

55

54

53

52

51

Rank

81.9

78.2

67.5

78.6

69.2

61.4

80.3

74.4

75.7

61.4

Answerability

62.1

76.6

66.7

76.7

68.2

61.8

75.0

77.1

81.3

71.0

Efﬁcacy

51.9

60.7

69.0

73.1

53.7

57.4

76.6

73.1

78.3

63.8

Effectiveness

48.1

64.3

63.8

64.3

73.2

77.8

74.1

72.4

63.0

62.0

Deliverability

38.6

58.0

59.3

60.5

61.1

68.0

68.5

65.4

61.5

70.8

Sustainability

Table 5. The 10 research options that achieved the lowest overall research priority score with average expert agreement.

52.4

60.4

61.9

55.6

76.1

64.6

60.0

73.1

70.5

82.5

Disease
burden
reduction

35.7

50.0

69.0

57.9

69.6

85.7

57.1

61.4

66.7

90.5

Equity

53.0

64.0

65.3

66.7

67.3

68.1

70.2

71.0

71.0

71.7

RPS

0.65

0.73

0.84

0.61

0.69

0.66

0.74

0.78

0.82

0.75

AEA

investing in. They are perhaps appropriate for more specialist organisations and funders with
more focused interests and priorities.

Limitations
We acknowledge our study weaknesses. CHNRI attempts to simplify a highly complex process
of priority setting, gathering together the opinions of a group of experts to bring coherence and
direction to a neglected research area. Some bias is inevitable in the selection of research questions. A longer list of initial questions had to be condensed down to make the survey accessible
for as many experts as possible. This was achieved by rephrasing to avoid duplication and repetition of similar concepts; others may have rephrased these questions differently than we did.
Response bias was also likely since those who are interested in infant <6m malnutrition are
more likely to respond to a survey on the topic than those who are not. This likely accounts for
our relatively low response rate to the questionnaire and is a problem common to all such
CHNRI-based assessments. We argue that it is not a serious challenge to the validity of the
study since those most interested and familiar with a topic are also in the best position to judge
how particular research questions might translate to subsequent practice or policy.
We note that governments and front-line fieldworkers in developing countries were not as
well represented (perhaps due to limited internet access to our online survey) as non-governmental organisation (NGO) staff and academics based in industrialised countries. It is possible
that these under-represented groups may have answered our questions differently. However,
the latter group has particular interest, experience, and expertise in the subject, and so we still
believe that their responses are valid.
Unlike some other CHNRI papers, we did not apply weights to our seven judging criteria
(according to how the different issues are valued). Our approach is clearer to report, but may
not reflect values in practice.
Finally, we focused on management of SAM, an “end point” on a continuum of acute malnutrition. Many of the research questions are applicable to moderate acute malnutrition since
the same challenges of how to identify cases and manage them effectively apply. Our focus on
SAM in this exercise prioritised those infants <6m with the most risk and also concurs with
the target group of the latest WHO guidance.

Potential Next Steps
Though often expensive, high-quality research is a vital investment towards future health and
social services that are effective and cost-effective. Many initiatives aim to improve research design, execution, and reporting so that questions are robustly answered [12,29,30]. More important is to ask the “right” research questions in the first place. We are pleased that our process
has highlighted case definitions as the number-one priority for infants <6m. Agreement on
this point is vital for the validity and comparability of all other studies. Data already exists, so
one ambition is for our CHNRI to catalyse discussions and meetings that will rapidly reach
workable consensus on this. This and other prioritisation results are consistent with ten research areas noted by WHO in 2013 (e.g., the need to better define infant <6m SAM; the need
to more clearly define therapeutic strategies) [11]. The added value of the CHNRI process and
framework is that it gives details and makes clear why certain questions matter and how they
might make an impact (e.g., some research questions may be easily answerable but may not
make much subsequent impact; others may be challenging (or expensive) to answer but have
great potential to improve future intervention effectiveness and sustainability). As well as overall ranking, CHRNI thereby exposes the strengths and weaknesses of numerous potential research options. It is in this that we see other next steps:
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• For researchers: our list will support individuals and institutions considering or applying for
research funding related to infant <6m SAM. Current focus areas can be compared with
those recognised by a wider community. Improving alignment (or justifying differences) between the two will help make a powerful case for investment.
• For funders: our list can be used to help shape grant calls and decide which projects to
ultimately fund.
We emphasise that we do not see our list as final or immutable but as a starting point for ongoing dialogue, development, and refinement of research options. As current top questions are
answered, others will take their place. Contexts will also change. What will always help, however, is having a framework to guide fair and rational discussions and decisions. Towards this, we
believe that the CHNRI approach has a key role to play.

Conclusions
The management of acute malnutrition in infants <6m (MAMI) is a critical area for child
health and nutrition; prioritising research is important for making the biggest advances as
quickly as possible. Our results suggest the need for a broad approach spanning basic epidemiology, health policies and systems, and more specialist interventions. Fundamental questions,
such as how to define SAM in infants <6m, are most urgent. Other priorities include research
on how to integrate MAMI into existing programmes and practices; how to provide appropriate breastfeeding support; and how to assess treatment coverage. The 2013 WHO SAM guidelines create an important stimulus to action. Our CHNRI builds on this by informing global
efforts and providing technical direction on an agreed-on and transparent operational research
agenda: maximising opportunities, avoiding duplication of effort and waste of resources, and
designing research that will most effectively inform policy change and front-line practice. All
ultimately lead to MAMI treatments with the biggest possible impact on infant <6m mortality,
morbidity, and nutrition.
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